Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Lam Research (LRCX, NASDAQ): To the Insiders -- Ignore unavailable to you. Want to Upgrade?

To: Proud_Infidel who wrote (5252)	2/24/2005 11:01:51 AM
From: Kirk ©	Read Replies (2) \| Respond to of 5867

"Volume is huge on LRCX today......a full day's volume in only one hour." I wonder if anyone has researched how much a poison pill costs shareholders in short term value? The mere fact big holders of the stock wanted it removed means people with money think it is holding back the value, at least that is how I read it. Poison pills are great if you own a ton of shares and think they are under valued by factors of integer numbers rather than tens of percent. When I bought LRCX back in 1998 at $3.33 and $4.00, I sure didn't want someone like AMAT or NVLS to buy my shares away from me for $5. I wanted $30 or $60. Now that it is 7 years later, it will cost more than $30, perhaps $45 to $60?